Results 241 to 250 of about 8,785 (292)
Some of the next articles are maybe not open access.

Biotransformation of Drugs

1978
During the past several years it has become generally accepted that the incidence of adverse reactions to drugs in patients increase with age (1–3). However, the reasons for the increased incidence are frequently obscure and often differ with the drug.
J R, Gillette, J A, Hinson
openaire   +2 more sources

The biotransformation of nitroglycerin

Biochemical Pharmacology, 1965
Abstract The transformation of nitroglycerin (NG) was accomplished by the formation of 1,2- and 1,3-dinitroglycerin. The dinitrates were resistant to further degradation and appeared as the urinary metabolites after the administration of NG. The dinitroglycerins were less active coronary vasodilators and blood pressure depressants than NG.
P, Needleman, J C, Krantz
openaire   +2 more sources

Biotransformation of Sevoflurane

Anesthesia & Analgesia, 1995
Several characteristics of sevoflurane biotransformation are apparent from the preceding investigations. Metabolism is rapid, with fluoride and HFIP appearing in plasma within minutes after the start of sevoflurane administration (38-40,51). Peak plasma fluoride concentrations generally occur within approximately 1 h after the termination of ...
openaire   +2 more sources

Biotransformation of Phencyclidine

Drug Metabolism Reviews, 1985
PCP is metabolized extensively in the body via a variety of metabolic routes. Biotransformation is a major mechanism of PCP elimination in humans and termination of PCP action in mice. In general, PCP metabolites are less active pharmacologically than PCP itself.
E J, Holsztynska, E F, Domino
openaire   +2 more sources

Biotransformation of alkaloids

2001
Biotransformations of alkaloids over the last decade have continued to encompass a wide variety of substrates and enzymes. The elucidation of novel alkaloid biosynthetic and catabolic pathways will continue to furnish new biocatalysts for the synthetic organic chemist.
Deborah A, Rathbone   +2 more
openaire   +3 more sources

Hepatocytes: The powerhouse of biotransformation

The International Journal of Biochemistry & Cell Biology, 2012
Liver is the most important organ involved in biotransformation of xenobiotics. Within the main organisational unit, the hepatocyte, is an assembly of enzymes commonly classified as phase I and phase II enzymes. The phase I enzymes principally cytochrome P450 catalyse both oxidative and reductive reactions of a bewildering number of xenobiotics.
Danielle K, Sevior   +2 more
openaire   +2 more sources

Biotransformations with Peroxidases

1999
Enzymes are chiral catalysts and are able to produce optically active molecules from prochiral or racemic substrates by catalytic asymmetric induction. One of the major challenges in organic synthesis is the development of environmentally acceptable chemical processes for the preparation of enantiomerically pure compounds, which are of increasing ...
W, Adam   +6 more
openaire   +2 more sources

Biotransformations

1996
Now in its seventh outstanding volume, Biotransformations has become established as a unique and important source for those involved in the discovery and development of new compounds. It broadly covers the scientific literature for the period 1987 to 1994. The series provides a complete survey of the biotransformations, in vertebrates, of the following:
D Kirkpatrick   +4 more
openaire   +1 more source

Identifying Functional Groups That Determine Rates of Micropollutant Biotransformations Performed by Wastewater Microbial Communities

Environmental Science & Technology, 2022
Michael T Zumstein   +2 more
exaly  

Biotransformation of Neuroleptanalgesics

International Anesthesiology Clinics, 1974
W, Soudijn   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy